Picture of Rigel Pharmaceuticals logo

RIGL Rigel Pharmaceuticals Balance Sheet

0.000.00%
us flag iconLast trade - 00:00
HealthcareSpeculativeSmall CapNeutral

Annual balance sheet for Rigel Pharmaceuticals, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

2019
December 31st
2020
December 31st
2021
December 31st
2022
December 31st
2023
December 31st
Period Length:
Source:10-K10-K10-K10-K10-K
Standards:
USG
USG
USG
USG
USG
Status:FinalFinalFinalFinalFinal
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments98.157.312558.256.9
Net Total Accounts Receivable
Net Total Receivables10.11615.540.330.6
Total Inventory
Prepaid Expenses
Total Current Assets1198915411699.3
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment27.920.611.92.791.03
Net Intangible Assets
Other Long Term Assets
Total Assets148110167134117
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities58.240.863.665.253.3
Long Term Debt
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities93.876.4137148146
Non Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity53.83430.4-13.6-28.6
Total Liabilities & Shareholders' Equity148110167134117
Total Common Shares Outstanding